We recently updated our Privacy Notice and Terms of Use.
Med-IQ
Thinking Beyond the Baby Boomers: Critical Considerations for HCV Identification and Care
PDF Publication PDF Publication

Thinking Beyond the Baby Boomers: Critical Considerations for HCV Identification and Care


This activity was developed by Med-IQ in collaboration with MedStar Health Research Institute.

Med-IQ      Duke Medicine
 

Released:
12/22/17
Expires:
12/21/18

Maximum Credits:

1.0
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

PDF Publication PDF Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
12/22/17

Expires:
12/21/18

Maximum Credits:
1.0
PDF Publication PDF Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
12/22/17
Expires:
12/21/18


Maximum Credits:
1.0


Overview: This CME/CE publication reviews guideline recommendations and current evidence for hepatitis C virus testing in asymptomatic patients and discusses the practical application of those guidelines in clinical practice. This activity also explores areas of emerging evidence and focus, particularly the management of women of childbearing potential and patients with substance use disorder.

CME Information:

Faculty
Dawn Fishbein, MD, MS
Scientific Director, Viral Hepatitis Research
MedStar Health Research Institute
Recruitment Module Director
Georgetown Howard Universities Center for Clinical and Translational Science CTSA
Associate Chair for Research, Department of Medicine
MedStar Washington Hospital Center
Washington, DC

Activity Planners
Sara C. Miller, MS
Director, QI Institute, CE Strategy and Content
Med-IQ
Baltimore, MD

Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Med-IQ
Baltimore, MD

Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD

Kathryn Schaefer, MSN, RN
Manager
Lead Nurse Planner
Med-IQ
East Lansing, MI

Writer
Anne Jacobson, MPH, CCMEP
Cocoa Beach, FL

Learning Objectives
Upon completion, participants should be able to:

  • Determine patient scenarios that trigger testing for chronic HCV infection based on contemporary guidelines
  • Identify strategies for the successful evaluation of contemporary and historical HCV risks due to illicit drug use
  • Integrate the HCV diagnostic process into current workflow

Target Audience
This activity is intended for primary care physicians, advanced practice nurses, physician assistants, and nurses.

Series Overview/Statement of Need
Since the release of birth cohort–based testing recommendations for hepatitis C virus (HCV) infection in late 2012, substantial efforts to improve HCV testing among persons born between 1945 and 1965 have occurred. Many of these efforts have been successful in improving the identification of previously unrecognized cases of chronic HCV infection; however, there remains a critical need for the improvement of risk-based testing, which is particularly relevant in light of the current epidemic of injection drug misuse. Evaluating patients for HCV risk factors that are more complicated than their birth year creates a significant challenge for busy providers. Many of these clinicians have had little exposure to HCV education and may lack expertise in the successful and efficient evaluation of risk. Frequently, patients do not readily disclose their risks to clinicians either due to fear of stigma or lack of awareness of risks—particularly risks associated with behaviors that may have occurred decades ago. Furthermore, many providers may be unaware of how their current practice aligns with clinical practice guidelines and validated performance measures. This focused initiative helps providers understand current clinical guidelines and evidence, evaluate the potential impact of changes in clinical care, and access resources to better serve their changing patient population.

Providership Statement
This activity was developed by Med-IQ in collaboration with MedStar Health Research Institute.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Med-IQ is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This nursing activity has been approved for up to 1.0 contact hour.

Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Medium/Method of Participation
This CME/CE activity consists of a 1.0-credit publication. To receive credit, complete the pre-survey, read the introductory CME/CE material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
 
Original Release Date: December 22, 2017
Expiration Date: December 21, 2018
Estimated Time to Complete This Activity: 1 hour

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
 
Dawn Fishbein, MD, MS
Contracted research: AbbVie Inc., Gilead Sciences, Inc., Merck & Co., Inc.
Ownership interest (stocks/stock options – excluding mutual funds): AbbVie Inc., Merck & Co., Inc.

The writer, peer reviewers, and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later

Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/

Google Chrome - latest version
Download: http://www.google.com/chrome

Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/

For technical support, go to https://www.med-iq.com/support-manual.html.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: https://www.Med-IQ.com/privacy-statement/.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.

Copyright
© 2017 Med-IQ, LLC

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.